BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 26712929)

  • 1. Neoepitope Vaccines Next Immunotherapy Frontier.
    Cancer Discov; 2016 Feb; 6(2):112. PubMed ID: 26712929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Personalized Oncology Meets Immunology: The Path toward Precision Immunotherapy.
    Mandal R; Chan TA
    Cancer Discov; 2016 Jul; 6(7):703-13. PubMed ID: 27107038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination therapies utilizing neoepitope-targeted vaccines.
    Lee KL; Schlom J; Hamilton DH
    Cancer Immunol Immunother; 2021 Apr; 70(4):875-885. PubMed ID: 33033852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioinformatics for Cancer Immunotherapy.
    Holtsträter C; Schrörs B; Bukur T; Löwer M
    Methods Mol Biol; 2020; 2120():1-9. PubMed ID: 32124308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Epitope peptide vaccine with oncoantigen for cancer and its biomarker].
    Hazama S; Maeda K; Oka M
    Nihon Rinsho; 2012 Dec; 70(12):2189-93. PubMed ID: 23259395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. It's a long way to the top (if you want to personalize immunotherapy).
    Haebe S; Weigert O
    J Immunother Cancer; 2017; 5():6. PubMed ID: 28116089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Precision medicine at Memorial Sloan Kettering Cancer Center: clinical next-generation sequencing enabling next-generation targeted therapy trials.
    Hyman DM; Solit DB; Arcila ME; Cheng DT; Sabbatini P; Baselga J; Berger MF; Ladanyi M
    Drug Discov Today; 2015 Dec; 20(12):1422-8. PubMed ID: 26320725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current Developments in Actively Personalized Cancer Vaccination with a Focus on RNA as the Drug Format.
    Diken M; Kreiter S; Kloke B; Sahin U
    Prog Tumor Res; 2015; 42():44-54. PubMed ID: 26383626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel tools to assist neoepitope targeting in personalized cancer immunotherapy.
    Saini SK; Rekers N; Hadrup SR
    Ann Oncol; 2017 Dec; 28(suppl_12):xii3-xii10. PubMed ID: 29092006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Researchers push for personalized tumour vaccines.
    Ledford H
    Nature; 2016 Apr; 532(7600):425. PubMed ID: 27121818
    [No Abstract]   [Full Text] [Related]  

  • 11. Whole-Exome Sequencing of Metastatic Cancer and Biomarkers of Treatment Response.
    Beltran H; Eng K; Mosquera JM; Sigaras A; Romanel A; Rennert H; Kossai M; Pauli C; Faltas B; Fontugne J; Park K; Banfelder J; Prandi D; Madhukar N; Zhang T; Padilla J; Greco N; McNary TJ; Herrscher E; Wilkes D; MacDonald TY; Xue H; Vacic V; Emde AK; Oschwald D; Tan AY; Chen Z; Collins C; Gleave ME; Wang Y; Chakravarty D; Schiffman M; Kim R; Campagne F; Robinson BD; Nanus DM; Tagawa ST; Xiang JZ; Smogorzewska A; Demichelis F; Rickman DS; Sboner A; Elemento O; Rubin MA
    JAMA Oncol; 2015 Jul; 1(4):466-74. PubMed ID: 26181256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutanome Engineered RNA Immunotherapy (MERIT).
    Hum Gene Ther Clin Dev; 2015 Jun; 26(2):84-6. PubMed ID: 26086755
    [No Abstract]   [Full Text] [Related]  

  • 13. Using Somatic Mutations to Guide Treatment Decisions: Context Matters.
    Horlings HM; Shah SP; Huntsman DG
    JAMA Oncol; 2015 Jun; 1(3):275-6. PubMed ID: 26181166
    [No Abstract]   [Full Text] [Related]  

  • 14. Preface.
    Tainsky MA; Morris RT
    Cancer Metastasis Rev; 2015 Mar; 34(1):3. PubMed ID: 25648358
    [No Abstract]   [Full Text] [Related]  

  • 15. Multi-epitope vaccines: a promising strategy against tumors and viral infections.
    Zhang L
    Cell Mol Immunol; 2018 Feb; 15(2):182-184. PubMed ID: 28890542
    [No Abstract]   [Full Text] [Related]  

  • 16. Counterpoint: Successes in the Pursuit of Precision Medicine: Biomarkers Take Credit.
    Kato S; Subbiah V; Kurzrock R
    J Natl Compr Canc Netw; 2017 Jul; 15(7):863-866. PubMed ID: 28687573
    [No Abstract]   [Full Text] [Related]  

  • 17. Mutation-Derived Tumor Antigens: Novel Targets in Cancer Immunotherapy.
    Finnigan JP; Rubinsteyn A; Hammerbacher J; Bhardwaj N
    Oncology (Williston Park); 2015 Dec; 29(12):970-2, 974-5. PubMed ID: 26676902
    [No Abstract]   [Full Text] [Related]  

  • 18. The regulatory landscape for actively personalized cancer immunotherapies.
    Britten CM; Singh-Jasuja H; Flamion B; Hoos A; Huber C; Kallen KJ; Khleif SN; Kreiter S; Nielsen M; Rammensee HG; Sahin U; Hinz T; Kalinke U
    Nat Biotechnol; 2013 Oct; 31(10):880-2. PubMed ID: 24104749
    [No Abstract]   [Full Text] [Related]  

  • 19. [Immunology of cancer].
    Abelev GI
    Vestn Ross Akad Med Nauk; 1999; (4):21-5. PubMed ID: 10377879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer vaccine and immunotherapy.
    Saleh FF
    Curr Pharm Des; 2005; 11(27):3459-60. PubMed ID: 16248800
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.